Company registration number 03423411 (England and Wales)
EMERGING SOLUTIONS PRODUCT LINES LIMITED
TRADING AS THERAPY
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
EMERGING SOLUTIONS PRODUCT LINES LIMITED
TRADING AS THERAPY
BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 1 -
2025
2024
£
£
£
£
Fixed assets
19,690
19,160
Current assets
72,692
57,809
Creditors: amounts falling due within one year
(17,860)
(8,400)
Net current assets
54,832
49,409
Total assets less current liabilities
74,522
68,569
Net assets
74,522
68,569
Capital and reserves
74,522
68,569
Notes to the financial statements
1
Employees

The average number of persons, including directors, employed by the company during the year wa s as follows:

2025
2024
Number
Number
Employees
5
5

Emerging Solutions Product Lines Limited is a private company limited by shares incorporated in England and Wales. The registered office is 249 Eachelhurst Road, Sutton Coldfield, West Midlands, United Kingdom, B76 1DT.

For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

(e) the company has relied on the specified exemption as a micro company contained in section 352 Companies Act 2014; the company has done so on the grounds that it is entitled to the benefit of that exemption as a small company and I confirm that the abridged financial statements have been properly prepared in accordance with section 353 Companies Act 2014.true

EMERGING SOLUTIONS PRODUCT LINES LIMITED
TRADING AS THERAPY
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025
31 March 2025
- 2 -
The financial statements were approved and signed by the director and authorised for issue on 27 October 2025
Miss E E Smith
Director
Company registration number 03423411 (England and Wales)
2025-03-31 2024-04-01 false false CCH Software CCH Accounts Production 2025.300 No description of principal activity Miss E E Smith Miss E E Smith false 03423411 2024-04-01 2025-03-31 03423411 2025-03-31 03423411 2024-03-31 03423411 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 03423411 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 03423411 2023-04-01 2024-03-31 03423411 bus:Director1 2024-04-01 2025-03-31 03423411 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 03423411 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 03423411 bus:Micro-entities 2024-04-01 2025-03-31 03423411 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 03423411 bus:CompanySecretary1 2024-04-01 2025-03-31 03423411 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP